Low-dose naltrexone to prevent intolerable morphine adverse events: a forgotten remedy for a neglected, global clinical need

Pain Med. 2015 Jun;16(6):1239-42. doi: 10.1111/pme.12704. Epub 2015 Feb 3.

Authors

William Raffaeli¹, Paola Indovina²

Affiliations

¹ ISAL Foundation, Institute for Research on Pain, Rimini, Italy.
² Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.

PMID: 25643645
DOI: 10.1111/pme.12704

No abstract available

Publication types

Letter

MeSH terms

Analgesics, Opioid / adverse effects*
Analgesics, Opioid / antagonists & inhibitors*
Chronic Pain / drug therapy
Chronic Pain / epidemiology
Dose-Response Relationship, Drug
Humans
Morphine / adverse effects*
Morphine / antagonists & inhibitors*
Naltrexone / administration & dosage*
Narcotic Antagonists / administration & dosage*
Neoplasms / drug therapy
Neoplasms / epidemiology

Substances

Analgesics, Opioid
Narcotic Antagonists
Naltrexone
Morphine